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Delocalized lipophilic cations (DLCs) penetrate plasma
and mitochondrial membranes and accumulate in mito-
chondria. The higher mitochondrial membrane poten-
tials of neoplastic vs normal cells, in general, account
for greater uptake and may be a way to selectively target
these cells since. Dequalinium (DQA) is a DLC and so
our goal is to evaluate the therapeutic potential of DQA
in cancer, namely in B-cell Chronic Lymphocytic Leu-
kaemia (B-CLL), Acute Promyelocytic Leukaemia (APL)
and Hepatocellular Carcinoma (HCC).
For this we used 3 cell lines, EHEB (B-CLL), HL-60
(APL) and HUH-7 (HCC), to evaluate the effect of dif-
ferent concentrations of DQA either by single dose
administration, by daily dose administration and by
association with conventional anticarcinogenic agents.
Cell viability and death was determined by the resazurin
assay, optical microscopy and by flow cytometry. The
latter was also used to evaluate the mitochondrial mem-
brane potential, the levels of ROS (H2O2;O 2
￿-)a n dt h e
antioxidant defense, Reduced Glutathione (GSH), using
fluorescent probes.
We found that DQA induced a decrease in cell viabi-
lity inducing cell death by late apoptosis/necrosis in a
time, dose and cell type dependent manner, with and
IC50 of 2.5, 4.7 and 7.5 μM at 48h of exposure, respec-
tively to HL-60, HUH-7 and EHEB. These effects may
be mediated by oxidative stress as we have observed and
increase in ROS production and a decrease in GSH
levels and in mitochondrial membrane potential. We
also observed that if DQA is administered on a daily
basis a much lower concentration is required to induce
the same effect. On the other hand, the association of
DQA with the conventional drug induces a synergistic
effect, because lower concentration of both drugs is
required to obtain the some effect.
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